Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,754
+$298 QoQ
Shares Held
75
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,531
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TORONTO DOMINION BANK holds $1,118,866,899 across 11 Drug Manufacturers - General names. NVS ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
242,914 | $291,358,362 | |
| 2 | JNJ |
Johnson & Johnson
|
761,198 | $193,321,455 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,468,613 | $188,716,770 | |
| 4 | ABBV |
AbbVie Inc.
|
611,061 | $153,767,389 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
952,712 | $120,365,632 | |
| 6 | AMGN |
Amgen Inc
|
181,652 | $65,779,821 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
926,930 | $53,409,706 | |
| 8 | PFE |
Pfizer Inc
|
1,756,923 | $42,306,705 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,754 | 75 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,456 | 75 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $51,701 | 375 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $48,090 | 375 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $38,723 | 320 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $33,444 | 300 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $29,193 | 300 | Shares | Defined | 2025-02-19 | |
| 2024-09-30 | $34,506 | 300 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $31,938 | 300 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $248,596 | 2,570 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $259,492 | 2,570 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $261,780 | 2,570 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $259,338 | 2,570 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $309,120 | 3,360 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $326,592 | 3,600 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $259,954 | 3,420 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $289,092 | 3,420 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $300,105 | 3,420 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $183,687 | 2,100 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $306,347 | 3,746 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,319,695 | 14,464 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,689,768 | 19,768 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,846,200 | 19,551 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,724,155 | 19,827 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,668,193 | 19,100 | Shares | Sole | 2020-08-28 | |
| 2020-03-31 | $12,454,319 | 151,053 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||